Quinolinic acid formation in immune-activated mice:: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl) thiazol-2yl]-benzenesulfonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase

被引:32
作者
Chiarugi, A [1 ]
Moroni, F [1 ]
机构
[1] Univ Florence, Dept Preclin & Clin Pharmacol, I-50134 Florence, Italy
关键词
quinolinic acid; immune-stimulation; kynurenine; selective kynurenine hydroxylase inhibitor; mNBA;
D O I
10.1016/S0028-3908(99)00048-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of kynurenine hydroxylase activity in the neo-formation of the excitotoxin quinolinic acid (QUIN) has been studied in mice by using (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl) thiazol-2yl]-benzenesulfonamide (Ro 61-8048), two potent and selective inhibitors of this enzyme. Immune-stimulation with pokeweed mitogen (PWM, 200 mu g i.v., 12 h) induced a robust increase in kynurenine (KYN) and its metabolites kynurenic acid (KYNA) and QUIN in blood and brain. When incubated in a medium containing KYN but not tryptophan, spleen, lung and liver (but not brain) slices accumulated a measurable amount of QUIN in the supernatant. Slices obtained from PWM treated animals had a ten-fold increase in QUIN accumulation in spleen, no changes in lung and a 40% decrease in liver, suggesting that the spleen contributes to the increased QUIN levels found in the blood and brain of immune-stimulated mice. Large doses of kynurenine hydroxylase inhibitors increased KYN and KYNA, but unexpectedly did not decrease QUIN content in control blood and brain. When tested in organ slices obtained from either controls or immune-stimulated animals, mNBA (1-1000 mu M) and Ro 61-8048 (0.1-100 mu M) strongly reduced QUIN neo-formation, suggesting that, in vitro, kynurenine hydroxylase activity is required for QUIN neosynthesis. Indeed, after repeated doses of, mNBA or Ro 61-8048, QUIN content in blood and brain of immune-stimulated animals significantly decreased. Our results suggest that, under basal conditions, sufficient QUIN synthesis may occur through kynurenine hydroxylase-independent pathways. In immune-stimulated animals, however, kynurenine hydroxylase inhibitors significantly reduce blood and brain accumulation of QUIN. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1225 / 1233
页数:9
相关论文
共 40 条
  • [1] PRESENCE OF 3-HYDROXYANTHRANILIC ACID IN RAT-TISSUES AND EVIDENCE FOR ITS PRODUCTION FROM ANTHRANILIC ACID IN THE BRAIN
    BARAN, H
    SCHWARCZ, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (03) : 738 - 744
  • [2] CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN
    BEUTLER, B
    CERAMI, A
    [J]. NATURE, 1986, 320 (6063) : 584 - 588
  • [3] Quinolinic acid accumulation in injured spinal cord: Time course, distribution, and species differences between rat and guinea pig
    Blight, AR
    Leroy, EC
    Heyes, MP
    [J]. JOURNAL OF NEUROTRAUMA, 1997, 14 (02) : 89 - 98
  • [4] INHIBITORS OF KYNURENINE HYDROXYLASE AND KYNURENINASE INCREASE CEREBRAL FORMATION OF KYNURENATE AND HAVE SEDATIVE AND ANTICONVULSANT ACTIVITIES
    CARPENEDO, R
    CHIARUGI, A
    RUSSI, P
    LOMBARDI, G
    CARLA, V
    PELLICCIARI, R
    MORONI, F
    MATTOLI, L
    [J]. NEUROSCIENCE, 1994, 61 (02) : 237 - 244
  • [5] CHIARUGI A, 1995, J NEUROCHEM, V65, P1176
  • [6] Chiarugi A, 1996, J NEUROCHEM, V67, P692
  • [7] NICOTINYLALANINE INCREASES CEREBRAL KYNURENIC ACID CONTENT AND HAS ANTICONVULSANT ACTIVITY
    CONNICK, JH
    HEYWOOD, GC
    SILLS, GJ
    THOMPSON, GG
    BRODIE, MJ
    STONE, TW
    [J]. GENERAL PHARMACOLOGY, 1992, 23 (02): : 235 - 239
  • [8] COZZI A, 1999, IN PRESS J CEREB BLO
  • [9] CYTO-TOXICITY OF 3-HYDROXYKYNURENINE IN A NEURONAL HYBRID CELL-LINE
    EASTMAN, CL
    GUILARTE, TR
    [J]. BRAIN RESEARCH, 1989, 495 (02) : 225 - 231
  • [10] FLANAGAN EM, 1995, J NEUROCHEM, V64, P1192